Cargando…

Dietary Quality and Relationships with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among United States Adults, Results from NHANES 2017–2018

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new definition for the evidence of hepatic steatosis and metabolic dysfunctions. The specific role of the dietary factors in the development and progress of the disease are not well illuminated. Thus, we conducted this study on the as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Ting, Zhang, Jingxian, Xie, Wei, Ni, Yunlong, Fang, Xinyu, Liu, Mao, Peng, Xianzhen, Wang, Jie, Dai, Yue, Zhou, Yonglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659246/ https://www.ncbi.nlm.nih.gov/pubmed/36364767 http://dx.doi.org/10.3390/nu14214505

Ejemplares similares

FRI036 Trends In The Racial And Ethnic Disparity Of Metabolic Associated Fatty Liver Disease (MAFLD): Data From NHANES 1988 To 2018
por: Shaheen, Magda, et al.
Publicado: (2023)

Dietary creatine and kidney function in adult population: NHANES 2017–2018
por: Ostojic, Sergej M.
Publicado: (2021)

Associations between Serum Vitamin A and Metabolic Risk Factors among Eastern Chinese Children and Adolescents
por: Tian, Ting, et al.
Publicado: (2022)

Multilevel Analysis of the Nutritional and Health Status among Children and Adolescents in Eastern China
por: Tian, Ting, et al.
Publicado: (2022)

Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis
por: Yao, Nan, et al.
Publicado: (2022)

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
por: Wang, Xiaolin, et al.
Publicado: (2022)

Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
por: Subramanian, Pallavi, et al.
Publicado: (2022)

The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018
por: Bae, Ji Cheol, et al.
Publicado: (2022)

Correlation of obesity, dietary patterns, and blood pressure with uric acid: data from the NHANES 2017–2018
por: Yao, Jia, et al.
Publicado: (2022)

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Associations between red blood cell count and metabolic dysfunction-associated fatty liver disease(MAFLD)
por: Dai, Xinyi, et al.
Publicado: (2022)

Association between Dietary Niacin Intake and Nonalcoholic Fatty Liver Disease: NHANES 2003–2018
por: Pan, Jie, et al.
Publicado: (2023)

Plant-based dietary patterns and fasting insulin: a cross-sectional study from NHANES 2017–2018
por: Curlin, Dana, et al.
Publicado: (2023)

Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2021)

Association of dietary fatty acid intake with hypertension in children and adolescents: evidence from the NHANES 2005–2018
por: Li, Xiumin, et al.
Publicado: (2023)

Sleeping, Smoking, and Kidney Diseases: Evidence From the NHANES 2017–2018
por: Wu, Chia-Chao, et al.
Publicado: (2021)

Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD
por: Chen, Jie, et al.
Publicado: (2023)

Association between dietary intake of anthocyanidins and heart failure among American adults: NHANES (2007–2010 and 2017–2018)
por: Tao, Zaixiao, et al.
Publicado: (2023)

Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
por: Cheng, Wenli, et al.
Publicado: (2023)

Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
por: Marschner, Rafael Aguiar, et al.
Publicado: (2023)

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
por: Sangro, Paloma, et al.
Publicado: (2023)

Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
por: Guo, Qin, et al.
Publicado: (2023)

Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017–2018
por: Razouki, Zayd Adnan, et al.
Publicado: (2022)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
por: Carnagarin, Revathy, et al.
Publicado: (2021)

A43 SEX DIFFERENCES IN THE ASSOCIATION OF HIV WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)
por: Kablawi, D, et al.
Publicado: (2023)

The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018
por: Liu, Jie, et al.
Publicado: (2022)

Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018
por: Yang, Zheng, et al.
Publicado: (2023)

Association between sleep duration and albumin in US adults: a cross-sectional study of NHANES 2015–2018
por: Li, Jingxian, et al.
Publicado: (2022)

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
por: Huang, Jiaofeng, et al.
Publicado: (2021)

NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III
por: Huang, Qi, et al.
Publicado: (2021)

Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
por: Cordeiro, Adryana, et al.
Publicado: (2022)

Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017–2018
por: Deng, Yunlei, et al.
Publicado: (2021)

Association between dietary anthocyanidins intake and depression among US adults: a cross-sectional study (NHANES, 2007–2010 and 2017–2018)
por: Chen, Wen-li, et al.
Publicado: (2023)

Correlation of muscle mass and bone mineral density in the NHANES US general population, 2017–2018
por: Qin, Hailin, et al.
Publicado: (2022)

Associations of Serum Uric Acid with Clustering of Cardiovascular Risk Factors and a 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Jiangsu Adults, China
por: Tian, Ting, et al.
Publicado: (2021)

From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
por: Kulkarni, Anand V., et al.
Publicado: (2023)

Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
por: Yang, Chenyu, et al.
Publicado: (2022)

FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
por: Gu, Zhan, et al.
Publicado: (2020)

Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy
por: Zhao, Jianan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9bjm4el541tss5l101pvjg8vgp